Table 1 Clinical details in the disease course
Timepoint | Symptoms | Pathogens | Treatment | Therapeutic response |
|---|---|---|---|---|
May 2022 | Abdominal pain, fever, arthrodynia | Mycobacterium gordonae (lymph node) | Anti-NTM | Discharged in stable condition and continued anti-NTM therapy at a local hospital |
June 2022 to July 2023 | Edema, abdominal pain | Mycobacterium intracellulare (blood), mycobacterium tuberculosis (ascites) | Anti-NTM, voriconazole, GC | Recurrent hospitalizations; temperature normalization with pulmonary lesion progression; clinical improvement following GC treatment |
February 2024 to May 2024 | Restricted movement of right upper limb and mouth, painful skin lesions | Suspected bacilli in a skin biopsy sample (anti-acid staining) | Methotrexate and anti-infection | Cutaneous and muscular symptoms resolution; presumed mortality |